Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-FR
Language English French
Date Updated 2020-04-22 2020-04-22
Drug Identification Number 02443945 02443945
Brand name JARDIANCE JARDIANCE
Common or Proper name Jardiance 90's Jardiance 90's
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients EMPAGLIFLOZIN EMPAGLIFLOZIN
Strength(s) 25MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 90's 90's
ATC code A10BK A10BK
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-04-28 2020-04-28
Actual start date
Estimated end date 2020-04-29 2020-04-29
Actual end date 2020-04-22
Shortage status Avoided shortage Anticipated shortage
Company comments Product arrival date improved, expected to arrive before running out of stock Product arrival date improved, expected to arrive before running out of stock Shortage report will be closed with "Actual end date" when product arrives
Health Canada comments